Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Off-the-shelf CD123 CAR-NK for R/R AML — Stella

Home/Acute Myeloid Leukemia, in Relapse/Off-the-shelf CD123 CAR-NK for R/R AML

View on ClinicalTrials.gov

Recruiting

Back to Acute Myeloid Leukemia, in Relapse trials

Off-the-shelf CD123 CAR-NK for R/R AML

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

Peking University People's Hospital, Beijing, Beijing Municipality

Key details

Phase

Very early testing

Sponsor

Peking University People's Hospital

Enrollment target

~12 participants

Started

December 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.